Skip to main content
. Author manuscript; available in PMC: 2013 Jun 3.
Published in final edited form as: Hear Res. 2011 Oct 31;283(0):169–179. doi: 10.1016/j.heares.2011.10.003

Fig. 4.

Fig. 4

Mean number (±SEM) of gentamicin immunolabeled neurons in the L-EVe at different timepoints post-injection from the ipsilateral and contralateral L-EVe in the same section (N = 4) for each group. Differences in the number of gentamicin immunolabeled neurons were observed between 1 and 3 days (LSD: p < 0.01), 7 and 14 days (LSD: p < 0.001), as well as between 14 and 30 days (LSD: p < 0.05) were statistically significant, but not between 3 and 7 days (LSD: p = 0.204). Comparisons of the number of gentamicin immunolabeled neurons between the ipsilateral L-EVe (gray bars) and the contralateral (black bars) were not statistically different for each group (paired-samples t test, p > 0.05). (*p < 0.05; **p < 0.01; ***p < 0.001).